SSR4 and bladder transitional cell carcinoma: To our surprising, chr1:110256304 on GSTM5, chr19: 40485814 on PSMC4 and chrX:153062943 on SSR4 were correlated with overall survival ratio (OS) and identified as prognostic editing sites in Glioblastoma multiforme (GBM), Bladder Urothelial Carcinoma (BLCA) and Kidney renal clear cell carcinoma (KIRC), respectively (Fig. 5C).